Beckman Coulter International S.A.
About Beckman Coulter
Beckman Coulter is the combination of two highly successful companies with distinguished histories. Beckman Instruments, Inc. (founded in the USA in 1934) and Coulter Corporation (founded in the late 1940s) united in 1997 to form a single entity that accounts for tens of thousands of analytical systems operating in laboratories around the world. The Corporation is a world leader in providing systems that simplify and automate laboratory processes used in all phases of the battle against disease. Beckman Coulter designs, manufacture, market and service a broad range of laboratory systems consisting of instruments, chemistries, software, and supplies that meet a variety of laboratory needs. Beckman Coulter products are used in a range of applications, from instruments used for pioneering medical research and drug discovery to diagnostic tools found in hospitals and physicians' offices.
The Company's diagnostics product lines cover virtually all blood tests routinely performed in hospital laboratories. For medical and pharmaceutical research, they provide a wide range of systems used in genomic, cellular and protein testing. The Company has approximately 125 000 systems operating in laboratories around the world, with 68% of annual revenues coming from after-market customer purchases of operating supplies, chemistry kits and service. Beckman Coulter markets their products in approximately 130 countries.
Beckman Coulter Nyon represents a large, varied and multicultural population of over 28 nationalities dedicated to improving patient health and reducing the cost of care. Leadership, Integrity and Teamwork are important attributes. We are driven by operational excellence in order to achieve highest customer satisfaction.
- Focus : Manufacturer
- Employees: 10,001+
- Industry : Diagnostics
News about Beckman Coulter
01-Feb-2019 | research and development
Beckman Coulter strenghtens laboratory automation business
Acquires of acoustic liquid handling company
09-Feb-2011 | business & finance
Danaher to Acquire Beckman Coulter, Inc. for $6.8 Billion
Danaher Corporation announced that it has entered into a definitive merger agreement with Beckman Coulter, Inc. pursuant to which Danaher will acquire ...
04-May-2007 | business & finance
Beckman Coulter and Biosite Amend Definitive Acquisition Agreement
Strategic Rationale and Economics of Combination Support Increased Price of $90 per Biosite Share
27-Mar-2007 | business & finance
Beckman Coulter to Acquire Biosite Incorporated
Beckman Coulter, Inc. and Biosite(R) Incorporated announced that they have entered into a definitive merger agreement under which Beckman Coulter will ...
24-Jul-2006 | business & finance
Beckman Coulter Licenses Roche`s Real Time PCR Patent Portfolio
Beckman Coulter, Inc. has acquired an In Vitro Diagnostics product license to all real-time polymerase chain reaction (PCR) patents and pending patent ...
06-Mar-2006 | people
Beckman Coulter Announces Management Change
Beckman Coulter, Inc. announced that James T. Glover, senior vice president and chief financial officer will retire from the company effective June 30, ...
26-Jan-2005 | people
Beckman Coulter Names Scott Garrett CEO
Beckman Coulter, Inc. announced that Scott Garrett has been named chief executive officer (CEO) of the corporation, effective February 21, 2005. Garrett, ...